Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance at 8 a.m. ET on February 9, 2022Business Wire • 01/18/22
Teva Pharmaceutical Industries Limited's (TEVA) CEO Kåre Schultz on 40th Annual JPMorgan Healthcare Conference- Conference Call TranscriptSeeking Alpha • 01/11/22
Teva's stock swings to a sharp loss after jury finds its U.S. subsidiary violated rights of New YorkersMarket Watch • 12/30/21
NYSE Traded Teva Pharmaceuticals To Market Cannabis Oils From Cannabit-Tikun Olam In Israel, Palestine, UkraineBenzinga • 12/27/21
First commercial and exclusive agreement signed between 'Teva Israel' and 'Cannbit-Tikun Olam' - for marketing and distribution of medical cannabis oilPRNewsWire • 12/27/21
Teva Announces Launch of First-to-Market Generic Version of Narcan® (Naloxone Hydrochloride Nasal Spray), in the U.S.Business Wire • 12/22/21